IMAGINE-TBM trial: Advancing Tuberculous Meningitis treatment to save lives
The IMAGINE-TBM trial, sponsored by the NIAID, aims to improve treatment for tuberculous meningitis (TBM) by comparing a six-month drug regimen with the standard nine-month regimen.